EPAS1 and laryngeal carcinoma: More than half of patients (56%) with advanced laryngeal carcinoma presented with mRNA HIF-1α upregulation (RQ > 2), and mRNA HIF-2α overexpression was evident in only 10% of the cases [Figure 1].